These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 23448573)

  • 1. Improving the therapeutic ratio in stereotactic radiosurgery: optimizing treatment protocols based on kinetics of repair of sublethal radiation damage.
    Andisheh B; Belkić D; Mavroidis P; Alahverdi M; Lind BK
    Technol Cancer Res Treat; 2013 Aug; 12(4):349-61. PubMed ID: 23448573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward improving the therapeutic ratio in stereotactic radiosurgery: selective modulation of the radiation responses of both normal tissues and tumor.
    Hopewell JW; Millar WT; Ang KK
    J Neurosurg; 2007 Jul; 107(1):84-93. PubMed ID: 17639878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment planning optimization for multiple arcs stereotactic radiosurgery using a linear accelerator.
    Lam CF; Zhu JG; Fenn JO; Jenrette JM
    Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):647-57. PubMed ID: 7558955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological optimization of tumor radiosurgery.
    Cappuccio A; Herrero MA; Nuñez L
    Med Phys; 2009 Jan; 36(1):98-104. PubMed ID: 19235378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Schedule of stereotactic radiotherapy: a study considering the factors of repair and cell proliferation].
    Shigematsu N; Kunieda E; Kawada T; Kitamura M; Kubo A; Dokiya T; Ito H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1998 Aug; 58(9):516-20. PubMed ID: 9778938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Choroidal melanoma stage T1 - comparison of the planning protocol for stereotactic radiosurgery and proton beam irradiation].
    Furdová A; Růžička J; Sramka M; Králik G; Chorváth M; Kusenda P
    Cesk Slov Oftalmol; 2012 Oct; 68(4):156-61. PubMed ID: 23214488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiobiological evaluation of the radiation dose as used in high-precision radiotherapy: effect of prolonged delivery time and applicability of the linear-quadratic model.
    Shibamoto Y; Otsuka S; Iwata H; Sugie C; Ogino H; Tomita N
    J Radiat Res; 2012; 53(1):1-9. PubMed ID: 21997195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing the time course of brachytherapy and other accelerated radiotherapeutic protocols.
    Brenner DJ; Hall EJ; Huang Y; Sachs RK
    Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):893-901. PubMed ID: 8040040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of (125)I stereotactic brachytherapy and LINAC radiosurgery modalities based on physical dose distribution and radiobiological efficacy.
    Viola A; Major T; Julow J
    Radiat Res; 2006 Jun; 165(6):695-702. PubMed ID: 16802870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new approach to computing normal tissue complication probability of an intensity-modulated radiotherapy treatment with stereotactic radiotherapy boost of nasopharyngeal carcinoma: a case study.
    Leung LH; Wong WK; Cheng AC; Kan MW; Cheung JY; Lam NK; Yuen KT; Yau CC
    Med Dosim; 2011; 36(2):138-44. PubMed ID: 20510601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimization of multiple-isocenter treatment planning for linac-based stereotactic radiosurgery.
    Liao R; Williams JA; Myers L; Li S; Taylor RH; Davatzikos C
    Comput Aided Surg; 2000; 5(4):220-33. PubMed ID: 11029156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Normal tissue complication probability estimation by the Lyman-Kutcher-Burman method does not accurately predict spinal cord tolerance to stereotactic radiosurgery.
    Daly ME; Luxton G; Choi CY; Gibbs IC; Chang SD; Adler JR; Soltys SG
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2025-32. PubMed ID: 21531516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis.
    Chang DT; Swaminath A; Kozak M; Weintraub J; Koong AC; Kim J; Dinniwell R; Brierley J; Kavanagh BD; Dawson LA; Schefter TE
    Cancer; 2011 Sep; 117(17):4060-9. PubMed ID: 21432842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing dose and fractionation for stereotactic body radiation therapy. Normal tissue and tumor control effects with large dose per fraction.
    Timmerman R; Bastasch M; Saha D; Abdulrahman R; Hittson W; Story M
    Front Radiat Ther Oncol; 2007; 40():352-365. PubMed ID: 17641519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimate of normal tissue damage in treatment planning for stereotactic radiotherapy.
    Benassi M; Begnozzi L; Gentile FP; Chiatti L; Carpino S
    Strahlenther Onkol; 1993 Oct; 169(10):612-6. PubMed ID: 8235986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modelling the influence of treatment time on the biological effectiveness of single radiosurgery treatments: derivation of "protective" dose modification factors.
    Jones B; Hopewell JW
    Br J Radiol; 2019 Jan; 92(1093):20180111. PubMed ID: 29745754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recovery from sublethal damage during intermittent exposures in cultured tumor cells: implications for dose modification in radiosurgery and IMRT.
    Shibamoto Y; Ito M; Sugie C; Ogino H; Hara M
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1484-90. PubMed ID: 15275736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription dose guideline based on physical criterion for multiple metastatic brain tumors treated with stereotactic radiosurgery.
    Sahgal A; Barani IJ; Novotny J; Zhang B; Petti P; Larson DA; Ma L
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):605-8. PubMed ID: 20472351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.